303-981-3117
End of Content.
+08 9229 8228
In Stock
Retatrutide is an experimental triple-hormone-receptor agonist being developed by Eli Lilly for the treatment of obesity, type 2 diabetes, and fatty liver disease. It works by mimicking three key hormones that regulate appetite, blood sugar, and metabolism.
Retatrutide is an experimental triple-hormone-receptor agonist being developed by Eli Lilly for the treatment of obesity, type 2 diabetes, and fatty liver disease. It works by mimicking three key hormones that regulate appetite, blood sugar, and metabolism.
Reviews
There are no reviews yet.